JNCE

Jounce Therapeutics, Inc. Common Stock

Delisted

JNCE was delisted on the 3rd of May, 2023.

84 hedge funds and large institutions have $64.1M invested in Jounce Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 21 increasing their positions, 20 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
84
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$136K
Puts
$10K
Net Calls
Net Calls Change

Top Sellers

1 -$5.99M
2 -$5.67M
3 -$4.05M
4
Morgan Stanley
Morgan Stanley
New York
-$2.85M
5
Millennium Management
Millennium Management
New York
-$2.46M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$9.81M
2
$7.88M
3
$5.85M
4
$5.33M
5
$4.71M
6
$3.9M
7
$2.89M
8
$2.1M
9
$2.01M
10
$1.71M
11
$1.49M
12
$1.42M
13
$1.13M
14
$1.13M
15
$1.07M
16
$974K
17
$925K
18
$836K
19
$786K
20
$740K
21
$616K
22
$601K
23
$510K
24
$489K
25
$451K